Patents by Inventor J. Vaughan
J. Vaughan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9612849Abstract: An active workstation is provided and includes a first support element, a computing device to which peripheral devices, which are movably disposed on the first support element, are coupled and a second support element movably disposed proximate to the first support element. The computing device includes a processing unit and a memory having executable instructions stored thereon. When executed, the executable instructions cause the processing unit to facilitate respective operations and movements of the peripheral devices and the second support element in accordance with a user profile.Type: GrantFiled: November 5, 2015Date of Patent: April 4, 2017Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATIONInventors: Michael E. Gildein, II, Vijai Kalathur, Rajaram B. Krishnamurthy, Moses J. Vaughan
-
Patent number: 9613517Abstract: A method, computer program product, and system for object location managing. The method including generating a first list including one or more personal objects based on a personal schedule of a user, generating a second list including one or more personal objects physically located within a predefined range of a checkpoint, comparing the first list to the second list to determine which personal objects are on both lists and which personal objects are missing, if any, from the second list, and notifying the user with the results of the comparison between the first list and the second list by activating an alarm.Type: GrantFiled: October 29, 2015Date of Patent: April 4, 2017Assignee: International Business Machines CorporationInventors: Michael E. Gildein, II, Vijai Kalathur, Rajaram B. Krishnamurthy, Christine D. Mikijanic, Moses J. Vaughan
-
Publication number: 20170085686Abstract: A puzzle-style modular electronic device is provided. The puzzle-style modular electronic device is activated based on detecting an interconnection of a plurality of block modules and determining whether the interconnection of the plurality of block modules matches an assembly orientation. Note that each of the plurality of block modules includes a processor, a memory, and at least one connection point through which the interconnection is established and that the interconnection of the plurality of block modules collectively forms the modular electronic device. Further, the puzzle-style modular electronic device authenticates a set of operations of the modular electronic device in response to the determining that the interconnection of the plurality of block modules matches the assembly orientation.Type: ApplicationFiled: September 18, 2015Publication date: March 23, 2017Inventors: James P. Gilchrist, Michael E. Gildein, Rajaram B. Krishnamurthy, Moses J. Vaughan
-
Publication number: 20170086105Abstract: A modular electronic device including a master core and a plurality of communication radio modules is provided. The modular electronic device maximizes communication performance by receiving a request for network operations from a mobile operating system of the modular electronic device; polling a table to determine a capacity of each communication radio module; and assigning the network operations to a module of the communication radio modules with a highest available capacity to maximize the communication performance of the modular electronic device.Type: ApplicationFiled: September 22, 2015Publication date: March 23, 2017Inventors: James P. Gilchrist, Michael E. Gildein, Rajaram B. Krishnamurthy, Daniel Rogers, Moses J. Vaughan
-
Publication number: 20170076713Abstract: An approach for augmenting a teleconference based on cognitive computing. A teleconference transcript is created based on speech-to-text conversion. A portion of the teleconference transcript is replaced based on a substitute word store and on cognitive computing text substitution. A second teleconference transcript and text-to-speech conversion creates augmented real-time audio. Participant audio and augmented audios are combined to create and output augmented audio to teleconference participants. Audio augmentation includes noise reduction, volume normalization, content change and natural language translation.Type: ApplicationFiled: September 14, 2015Publication date: March 16, 2017Inventors: Michael E. Gildein, II, Vijai Kalathur, Rajaram B. Krishnamurthy, Moses J. Vaughan
-
Publication number: 20170068921Abstract: Embodiments include method, systems and computer program products for performing summarization of a recording based on biometric and business process data. Aspects include receiving a recording of a customer service representative performing a task, receiving a biometric data from a sensor configured to monitor the customer service representative during the performance of the task and obtaining a business process data relating to one or more of the task and the customer service representative. Aspects also include identifying one or more portions of interest from the recording based on one or more of the biometric data and the business process data and compiling the one or more portions of interest into a summarization of the task.Type: ApplicationFiled: October 27, 2015Publication date: March 9, 2017Inventors: ELI M. DOW, ERIN M. FARR, MICHAEL E. GILDEIN, II, MOSES J. VAUGHAN
-
Publication number: 20170068920Abstract: Embodiments include method, systems and computer program products for performing summarization of a recording based on biometric and business process data. Aspects include receiving a recording of a customer service representative performing a task, receiving a biometric data from a sensor configured to monitor the customer service representative during the performance of the task and obtaining a business process data relating to one or more of the task and the customer service representative. Aspects also include identifying one or more portions of interest from the recording based on one or more of the biometric data and the business process data and compiling the one or more portions of interest into a summarization of the task.Type: ApplicationFiled: September 4, 2015Publication date: March 9, 2017Inventors: ELI M. DOW, ERIN M. FARR, MICHAEL E. GILDEIN, II, MOSES J. VAUGHAN
-
Publication number: 20170061459Abstract: A method for presenting a formulated fair price range for a vehicle on a mobile computing platform in an augmented reality format. Embodiments of the present invention receive a digital image of a vehicle, identify distinguishing characteristics of the vehicle, cross reference those characteristics with multiple databases to identify the unique vehicle or vehicle type, retrieve from other databases data relating to the value of the vehicle or vehicle type and analyze and correlate the data to formulate a fair price range for the vehicle that is presented as a virtual image superimposed over the vehicle in the digital image. The data relating to vehicle value include crime data for a particular geographic area, crime data against different types of vehicles and geographic and environmental considerations such as climate and weather patterns or popularity and buying trends. A corresponding computer program product and computer system are also disclosed herein.Type: ApplicationFiled: September 1, 2015Publication date: March 2, 2017Inventors: Eli M. Dow, Erin M. Farr, Moses J. Vaughan
-
Publication number: 20170061506Abstract: A method for presenting a formulated fair price range for a vehicle on a mobile computing platform in an augmented reality format. Embodiments of the present invention receive a digital image of a vehicle, identify distinguishing characteristics of the vehicle, cross reference those characteristics with multiple databases to identify the unique vehicle or vehicle type, retrieve from other databases data relating to the value of the vehicle or vehicle type and analyze and correlate the data to formulate a fair price range for the vehicle that is presented as a virtual image superimposed over the vehicle in the digital image. The data relating to vehicle value include crime data for a particular geographic area, crime data against different types of vehicles and geographic and environmental considerations such as climate and weather patterns or popularity and buying trends. A corresponding computer program product and computer system are also disclosed herein.Type: ApplicationFiled: February 4, 2016Publication date: March 2, 2017Inventors: Eli M. Dow, Erin M. Farr, Moses J. Vaughan
-
Patent number: 9565599Abstract: A modular electronic device including a master core and a plurality of communication radio modules is provided. The modular electronic device maximizes communication performance by receiving a request for network operations from a mobile operating system of the modular electronic device; polling a table to determine a capacity of each communication radio module; and assigning the network operations to a module of the communication radio modules with a highest available capacity to maximize the communication performance of the modular electronic device.Type: GrantFiled: October 21, 2015Date of Patent: February 7, 2017Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATIONInventors: James P. Gilchrist, Michael E. Gildein, Rajaram B. Krishnamurthy, Daniel Rogers, Moses J. Vaughan
-
Publication number: 20170010154Abstract: A miniaturized spectrometer capable of being held and carried in a person's hand and including all of the necessary elements for reliable quantification and characterization for laboratory purposes, of a variety of objects, including an analyte in solution, and that is also optionally adaptable for analysis of an analyte in gaseous phase, and/or on or imbedded in a solid surface.Type: ApplicationFiled: January 23, 2015Publication date: January 12, 2017Inventors: Thomas M. Spudich, Bradley L. Postier, Jermey D. Weter, Miranda Adams, Ethan J. Vaughan
-
Patent number: 9495399Abstract: An aspect of providing augmented reality model comparison and deviation detection includes receiving a three-dimensional (3D) model of an object that is associated with a domain, determining a set of characteristics of the object from the 3D model, and searching a domain-specific database for data matching the set of characteristics. The domain-specific database corresponds to the domain associated with the object. An aspect also includes determining an identification of the object from data in the domain-specific database that matches the set of characteristics. For each characteristic in the set of characteristics, and aspect further includes comparing each value of the characteristic to a corresponding value in the matching data of the domain-specific database, and calculating any variation between the corresponding value of the characteristic and the value of the matching data. Another aspect includes creating a searchable index of the matching data and corresponding variations.Type: GrantFiled: November 24, 2015Date of Patent: November 15, 2016Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATIONInventors: Eli M. Dow, Erin M. Farr, Michael E. Gildein, II, Moses J. Vaughan
-
Patent number: 8753633Abstract: Human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor ? (hTNF?) are disclosed. These antibodies have high affinity for hTNF? (e.g., Kd=10?8 M or less), a slow off rate for hTNF? dissociation (e.g., Koff=10?3 sec?1 or less) and neutralize hTNF? activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hTNF? and for inhibiting hTNF? activity, e.g., in a human subject suffering from a disorder in which hTNF? activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.Type: GrantFiled: June 15, 2012Date of Patent: June 17, 2014Assignee: AbbVie Biotechnology Ltd.Inventors: Jochen G. Salfeld, Deborah J. Allen, Zehra Kaymakcalan, Boris Labkovsky, John A. Mankovich, Brian T. McGuinness, Andrew J. Roberts, Paul Sakorafas, Hendricus R. J. M. Hoogenboom, David Schoenhaut, Tristan J. Vaughan, Michael White, Alison J. Wilton
-
Publication number: 20130330357Abstract: Human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor ? (hTNF?) are disclosed. These antibodies have high affinity for hTNF? (e.g., Kd=10?8 M or less), a slow off rate for hTNF? dissociation (e.g., Koff=10?3 sec?1 or less) and neutralize hTNF? activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hTNF? and for inhibiting hTNF? activity, e.g., in a human subject suffering from a disorder in which hTNF? activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.Type: ApplicationFiled: August 12, 2013Publication date: December 12, 2013Applicant: ABBVIE BIOTECHNOLOGY LTDInventors: Jochen G. Salfeld, Deborah J. Allen, Zehra Kaymakcalan, Boris Labkovsky, John A. Mankovich, Brian T. McGuinness, Andrew J. Roberts, Paul Sakorafas, Hendricus R.J.M. Hoogenboom, David Schoenhaut, Tristan J. Vaughan, Michael White, Alison J. Wilton
-
Publication number: 20130330356Abstract: Human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor ? (hTNF?) are disclosed. These antibodies have high affinity for hTNF? (e.g., Kd=10?8 M or less), a slow off rate for hTNF? dissociation (e.g., Koff=10?3 sec?1 or less) and neutralize hTNF? activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hTNF? and for inhibiting hTNF? activity, e.g., in a human subject suffering from a disorder in which hTNF? activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.Type: ApplicationFiled: August 12, 2013Publication date: December 12, 2013Applicant: ABBVIE BIOTECHNOLOGY LTD.Inventors: Jochen G. Salfeld, Deborah J. Allen, Zehra Kaymakcalan, Boris Labkovsky, John A. Mankovich, Brian T. McGuinness, Andrew J. Roberts, Paul Sakorafas, Hendricus R.J.M. Hoogenboom, David Schoenhaut, Tristan J. Vaughan, Michael White, Alison J. Wilton
-
Publication number: 20130115224Abstract: Human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor ? (hTNF?) are disclosed. These antibodies have high affinity for hTNF? (e.g., Kd=10?8 M or less), a slow off rate for hTNF? dissociation (e.g., Koff=10?3 sec?1 or less) and neutralize hTNF? activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hTNF? and for inhibiting hTNF? activity, e.g., in a human subject suffering from a disorder in which hTNF? activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.Type: ApplicationFiled: January 8, 2013Publication date: May 9, 2013Inventors: Jochen G. SALFELD, Deborah J. Allen, Zehra Kaymakcalan, Boris Labkovsky, John A. Mankovich, Brian T. McGuinness, Andrew J. Roberts, Paul Sakorafas, Hendricus R.j.m. Hoogenboom, David Schoenhaut, Tristan J. Vaughan, Michael White, Alison J. Wilton
-
Patent number: 8414894Abstract: Human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor ? (hTNF?) are disclosed. These antibodies have high affinity for hTNF? (e.g., Kd=10?8 M or less), a slow off rate for hTNF? dissociation (e.g., Koff=10?3 sec?1 or less) and neutralize hTNF? activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hTNF? and for inhibiting hTNF? activity, e.g., in a human subject suffering from a disorder in which hTNF? activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.Type: GrantFiled: December 30, 2011Date of Patent: April 9, 2013Assignee: Abbott Biotechnology Ltd.Inventors: Jochen G. Salfeld, John A. Mankovich, Deborah J. Allen, Hendricus R.J.M. Hoogenboom, Boris Labkovsky, Brian T. McGuinness, Paul Sakorafas, Michael White, Alison J. Wilton, Zehra Kaymakcalan, Andrew J. Roberts, David Schoenhaut, Tristan J. Vaughan
-
Patent number: 8372400Abstract: Human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor ? (hTNF?) are disclosed. These antibodies have high affinity for hTNF? (e.g., Kd=10?8 M or less), a slow off rate for hTNF? dissociation (e.g., Koff=10?3 sec?1 or less) and neutralize hTNF? activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hTNF? and for inhibiting hTNF? activity, e.g., in a human subject suffering from a disorder in which hTNF? activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.Type: GrantFiled: October 13, 2009Date of Patent: February 12, 2013Assignee: Abbott Biotechnology Ltd.Inventors: Jochen G. Salfeld, Deborah J. Allen, Zehra Kaymakcalan, Boris Labkovsky, John A. Mankovich, Brian T. McGuinness, Andrew J. Roberts, Paul Sakorafas, Hendricus R. J. M. Hoogenboom, David Schoenhaut, Tristan J. Vaughan, Michael White, Alison J. Wilton
-
Patent number: 8372401Abstract: Human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor ? (hTNF?) are disclosed. These antibodies have high affinity for hTNF? (e.g., Kd=10?8 M or less), a slow off rate for hTNF? dissociation (e.g., Koff=10?3 sec?1 or less) and neutralize hTNF? activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hTNF? and for inhibiting hTNF? activity, e.g., in a human subject suffering from a disorder in which hTNF? activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.Type: GrantFiled: May 8, 2012Date of Patent: February 12, 2013Assignee: Abbott Biotechnology Ltd.Inventors: Jochen G. Salfeld, Deborah J. Allen, Hendricus R. J. M. Hoogenboom, Zehra Kaymakcalan, Boris Labkovsky, John A. Mankovich, Brian T. McGuinness, Andrew J. Roberts, Paul Sakorafas, David Schoenhaut, Tristan J. Vaughan, Michael White, Alison J. Wilton
-
Patent number: D689182Type: GrantFiled: August 22, 2012Date of Patent: September 3, 2013Assignee: Hewlett-Packard Development Company, L.P.Inventors: Keith J. Kuehn, Brooks J. Vaughan